17th Annual Oxford International Conference on the Science of Botanicals
 • April 3rd - 6th, 2017
 • Oxford, Mississippi


Day 1 (Saturday, April 12th, 2008)

  • 2:00 - 5:15 On Site Registration – Oxford Conference Center (OCC) Lobby
  • 5:15 - 6:00 Introductory Remarks: Oxford Conference Center (OCC) Auditorium

Introducory Remarks (OCC Auditorium)

Ikhlas Khan, Ph.D., Assistant Director, NCNPR.
Barbara G. Wells, Pharm.D., FCCP, BCPP, Dean and Professor
Executive Director of the Research Institute of Pharmaceutical Sciences
Alice M. Clark, Ph.D., Vice-Chancellor for Research and Sponsored Programs.

Keynote Speaker: (OCC Auditorium)

Josephine Briggs, Ph.D., Director, National Center for Complementary and Alternative Medicine.

  • 6:00 - 8:00 Reception Oxford Conference Center (OCC) Cedar Room

Day 2 (Sunday, April 13th, 2008)

Session 1 - Plenary: Perspectives on Modern Approaches to Pharmacognosy - OCC Auditorium

Session Chair: A. Douglas Kinghorn, Ohio State University

Concurrent Session 2a: Impact of Natural Products on Tropical Diseases - OCC Magnolia Room
Session Chair: Stephen Cutler, The University of Mississippi

Concurrent Session 2b: Botanical Raw Materials - Issues of Sourcing/Supply and Quality- OCC Auditorium
Session Chair: Edward Croom Jr., The University of Mississippi

Session 3: Poster Session - Drill Hall (6:00 – 7:30).
Session Chair: Steven Dentali, American Herbal Products Association

Day 3 (Monday, April 14th, 2008)

Session 4 - Plenary: Active Principles of Medicinal Plants
OCC Auditorium
Session Chair: John Cardellina II, Reeves Group

  • 8:15 - 9:00 (S-14) Brigitte Kopp, University of Vienna, New Results From Well-known Herbal Medicinal Products.
  • 9:00 - 9:45 (S-15) A. Douglas Kinghorn, Ohio State University, Search for Bioactive Constituents of Botanical Dietary Supplements.
  • 9:45 - 10:15 Break
  • 10:15 - 11:00 (S-16) De-an Guo, Shanghai Research Center for Modernization of Traditional Chinese Medicine, Traditional Chinese Medicine: From Experience Towards Evidence-Based Medicine.
  • 11:00 - 11:45 (S-17) David S. Pasco, The University of Mississippi, The Majority of in vitro Macrophage Activation Exhibited by Extracts of some Immune Enhancing Botanicals is Due to Bacterial Lipoproteins and Lipopolysaccharide.
  • 11:45 - 1:00 Lunch – Oxford Conference Center Dining Hall

Concurrent Session 5a: Active Principles of Medicinal Plants
OCC Magnolia Room
Session Chair: Nikolaus Fischer, Former Chair of Pharmacognosy, The University of Mississippi.

  • 1:00 - 1:30 (S-18) Wei-Dong Zhang, Second Medical Military University, China, Studies on Effective Constituents of Chinese Herbal Drugs Based on Theory of TCM and Modern Bio-Technologies.
  • 1:30 - 2:00 (S-19) Bao-chang Cai, Nanjing University of Traditional Chinese Medicine, Investigation on Anti-inflammatory Effect and Chemical Constituents of Total Flavonoid Aglycones from Tibetan Medicine Oxytropis falcata.
  • 2:00 - 2:30 (S-20) Ge Lin, The Chinese University of Hong Kong, Identification of the Active Ingredient Accounting for the Biological Effects of Ligusticum chuanxiong.

Concurrent Session 5b: Analytical Approaches and Challenges for Quality Assessment of Botanicals
OCC Auditorium
Session Chair: Joesph Betz, Office of Dietary Supplements, National Institutes of Health

  • 1:00 - 1:30 (S-21) Paula Brown, BC Institute of Technology, Guidelines for Analytical Method Selection & Appropriate Use when Determining Chemical Constituents in Dietary Supplements.
  • 1:30 - 2:00 (S-22) Catherine A. Rimmer, National Institute of Standards and Technology, Analytical Challenges in the Certification of Botanical Dietary Supplement Standard Reference Materials.
  • 2:00 - 2:30 (S-23) Hwee Ling Koh, National University of Singapore, Challenges in the Quality Control of Botanical Medicine – a Singapore Perspective and Global Trend.

Excursion to Memphis, TN Busses Depart From OCC @ 4:00 Return to Oxford @ 10:00

Day 4 (Tuesday, April 15th, 2008)

Session 6: Plenary: Global Approaches to Botanicals
OCC Auditorium
Session Chair: Stephen O. Duke, USDA, ARS.

  • 8:15 - 9:00 (S-24) Christine Swanson, Office of Dietary Supplements, NIH, Botanical Research Centers Program (BRCP).
  • 9:00 - 9:45 K. Husnu Can Baser, Anadolu University, Turkey, Essential Oils - The Case of Oregano Oil and Carvacrol.
  • 9:45 - 10:15 Break
  • 10:15 - 11:00 (S-26) G. N. Qazi, CSIR, India, Approaches for the development of single plant based standardized formulations.
  • 11:00 - 11:45 Wei Yang, State Food and Drug Administration, China, Registration of New TCM products in China.
  • 11:45 - 1:00 Lunch – OCC Cedar Room Dining Hall

Concurrent Session 7a: Neuropharmacology of Botanicals
OCC Magnolia Room
Session Chair: Mahmoud A. ElSohly, The University of Mississippi

  • 4:30 - 6:30 Shuttles will take people from OCC to Hotels or for tours of the NCNPR or Medicinal Plant Garden. Please sign up for tours.

Concurrent Session 7b: Pharmacology, Pharmacokinetics and Interactions of Botanicals
OCC Auditorium
Session Chair: Elizabeth M. Calvey, FDA/CFSAN.

  • 1:00 - 1:30 (S-32) Adolf Nahrstedt, University of Muenster, Germany, Pharmacokinetic Synergy of Constituents in Herbal Medicinal Products.
  • 1:30 - 2:00 (S-33) Ping Li, China Pharmaceutical University, Herbal Medicine: Investigations on Bioactive Components, Pharmacokinetics and Quality Control Methods.
  • 2:00 - 2:30 (S-34) Xijun Wang, Heilongjiang University of Traditional Chinese Medicine, Bioacitivities Evaluation and Pharmacokinetics of 5-hydroxymethyl-2-furoic acid Derived from the Administration of Liu-Wei-Di-Huang-Wan.
  • 2:30 - 3:00 Break
  • 3:00 - 3:20 (O-4) Nicholas H. Oberlies, Research Triangle Institute, Identification of a Cranberry Juice Product Capable of Inhibiting Enteric CYP3A-Mediated First-Pass Metabolism in Humans.
  • 3:20 - 3:40 (O-5) Joel J. Gagnier, Jamieson Laboratories Limited, Improving the Quality of Reporting of Randomized Controlled Trials Evaluating Herbal Interventions: Implementing the CONSORT Statement.
  • 3:40 - 4:00 (O-6) Saleh A. Turujman, FDA/CFSAN/ONPLDS, Overview of Regulatory and Scientific Considerations of an NDI Review under DSHEA.
  • 4:00 - 6:30 Shuttles will take people from OCC to Hotels or for tours of the NCNPR or Medicinal Plant Garden. Please sign up for tours.

Day 5 (Wednesday, April 16th, 2008)

Session 8 - Plenary: Critical Issues with Botanicals
OCC Auditorium
Session Chair: Vasilios (Bill) Frankos, CFSAN/FDA/ONPLDS

Concurrent Session 9a: Antitumor Natural Products - Cytotoxins vs Targeted Agents OCC Magnolia Room
Session Chair: James D. McChesney, ChromaDex, Inc.

  • 1:00 - 1:30 (S-44) David Kroll, Research Triangle Institute, Pure Flavonolignans from Extracts of Milk Thistle (Silybum marianum) Against Models of Human Prostate Cancer
  • 1:30 - 2:00 (S-42) Yang Ye, Shanghai Institute of Materia Medica, Naturally Occurring Homoisoflavonoids as Potent Protein Tyrosine Kinases Inhibitors
  • 2:00 - 2:30 (S-43) Shi-shan Yu, Shanghai Institute of Materia Medica, Study on Bioactive Compounds with Molecular Diversity from Toxic Plants
  • 2:30 - 3:00 Break
  • 3:00 - 3:30 (S-41) Ruiwen Zhang, University of Alabama at Birmingham, Oncogenes as Molecular Targets for Natural Product Cancer Preventive and Therapeutic Agents
  • 3:30 - 3:50 (O-7) Yu-Dong Zhou, The University of Mississippi, Alpinumisoflavone, Methylalpinumisoflavone and Rotenone - Lonchocarpus glabrescens Metabolites that Inhibit HIF-1 Activation and Tumor Cell Migration
  • 3:50 - 6:30 Shuttles will take people from OCC to Hotels.

Concurrent Session 9b: Regulatory Issues for Botanicals - Quality, Research, cGMPs
OCC Auditorium
Session Chair: Jeanne I. Rader, Office of Regulatory Science/CFSAN/FDA